SUMMARY The predictive value of a diagnostic test estimates the likelihood for presence or absence of disease in a patient with a positive or negative test result (PV,O, or PVYR.,). We evaluated the predictive values of serum activities of the heart-specific creatine kinase isoenzyme MB (CK-MB), aspartate aminotransferase, lactate dehydrogenase, CK, and ECG in 401 consecutively admitted patients suspected of acute myocardial infarction (AMI). The study showed that CK-MB (PVPOI = 0.98, PV.g, = 1.00) was better than the other enzymes (single as well as serial) and ECG, evaluated both separately and in combinations. In all cases of AMI CK-MB was positive within 17 hours from admission. Replacement of the standard enzymes with CK-MB provides a faster and safer diagnosis of AMI and reduces hospitalization time considerably for patients without AMI. THE BALANCE between increased health care costs vs mortality and morbidity makes cost-effectiveness studies necessary.'3 As laboratory services increase tne costs in this field must be spent wisely. Although the technical reliability of a laboratory test is important, only the diagnostic validity and consequences for patients can justify its use. most common causes of death2 and one of the most frequent causes of hospitalization in the Western world, so many attempts have been made to improve its diagnosis.4-9 Detection of myocardial damage by increasing serum concentrations of enzymes as creatine kinase (CK), aspartate aminotransferase (ASAT), and lactate dehydrogenase (LDH) are now widely used to diagnose AMI.' 6 Recent studies indicate that measurements of the CK isoenzyme MB (CK-MB) in serum are more sensitive and specific in diagnosis of AMI.10-' However, several of these reports do not meet the criteria for establishing the true diagnostic efficacy20' 21 of CK-MB. The comparative patient group should consist of patients suspected of AMI and the establishment of the true diagnosis should be done independently of the results of CK-MB measurements. Furthermore, only a few of these studies answer the clinically important problem of the likelihood of AMI if a positive or negative CK-MB result is found in a patient suspected of AMI. 1 18,s 19 In the present study we compared the diagnostic value of CK-MB with that of ECG and the three standard enzymes (ASAT, CK and LDH) used as single or serial values and in different combinations. The study was done with regard to economical cost-effectiveness and to patient care.
Patients and Methods Patients
In a period of 6 AMI.25 Two criteria for a positive enzyme test were used: A single enzyme test was positive if one of the blood samples had an enzyme activity above the discriminatory level; a serial enzyme test was positive if a significant rise and fall in serum enzyme activities were seen. The significance level of enzyme changes was expressed as a rise and fall of more than v2si-2 of the analysis interassay variation.
Presentation of Results
The results of the enzyme tests and of ECG were classified as follows: true positive if the test was positive in an AMI patient; false negative if the test was negative in an AMI patient; true negative when a negative test was found in a patient without AMI; and false positive when a positive result occurred in a patient without AMI ( fig. 1) .
The zyme tests, whereas the lower effectiveness of CK-MB was caused by an increase in false-negative tests. Table 4 shows that the predictability of two combinations of single standard enzyme tests is better than ASAT, LDH or CK alone (table 2). The diagnostic effectiveness is lower when three rather than two enzymes are used, owing to an increased number of false-positive results. The combination of three enzymes with the ECG gives the same effectiveness as two enzymes. 22 ,000 are admitted each year for suspected AMI, and the diagnosis is confirmed in 1 1,000. In the present series of patients with suspected AMI, we estimated that 30% did not require hospitalization as soon as AMI was excluded, corresponding to 1320 patients per 1 million inhabitants per year. Table 6 gives the mean time to discharge using the WHO criteria or the CK-MB single test for diagnosis. For the 30% of the patients whose condition allowed discharge if AMI was disproved, the actual mean time in-hospital was 2.4 days, whereas the calculated maximal hospitalization was 1.5 days for diagnosis by CK-MB. With blood sampling at admission at 8 a.m. and 8 p.m. all cases of AMI had a positive CK-MB value within 17 hours from admission ( fig. 2 ). An average of 18 hours elapsed from blood sampling until the CK-MB results were available to the clinician, allowing for patient discharge for those in whom AMI was excluded. Table 6 shows that replacement of the older enzymes with CK- MB would reduce the hospitalization by about 40% in 30% of all the admissions who are referred with a suspected AMI.
Discussion
The aim of any diagnostic procedure is to show the presence or absence of a disease. The diagnostic accuracy of tests may be expressed in terms of specificity and sensitivity. These indicate the likelihood of a positive or negative test in patients with established diagnosis, and are therefore of minor interest to the clinician. The main concern is the probability of disease if the patient has a given test result. The final answer is given by establishing the predictive value for a positive or negative test result20, 27 as done in the present study for CK-MB in the diagnosis of AMI.
The present study evaluates The prognosis of the patients with CK-MB values between 5-30 U/1 is unknown. It should be noted that these patients were not ready for discharge. In fact, of the 46 patients in this CK-MB range, 25 had prolonged and severe attacks of angina during admission and 21 had severe heart failure (with pulmonary edema in 12). Animportant question is whether the mortality of the patients with CK-MB values between 5-30 U/1 is the same as in the patients with CK-MB lower than 5 U/1. This is being investigated.
The rapid rise and short duration of the CK-MB elevation and the very low rate of false-positive results establish an earlier diagnosis of AMI than that obtained by serial analysis of the other enzymes. Another practical advantage of CK-MB measurements is that the interpretation of one CK-MB result is simple compared with serial analysis of two or three enzymes.29 Furthermore, CK-MB analysis probably reduces the number of patients in whom the presence or absence of AMI cannot be established by present methods.
The ability to establish an early and reliable diagnosis of AMI has marked benefits. A shorter time needed for correct diagnosis is very desirable, since this observation period is a considerable strain for most patients. Furthermore, the monitored beds in the CCU will be more appropriately used. We estimate that about 1400 hospital days can be saved per million inhabitants per year if CK-MB is used for diagnosis of AMI instead of the present methods. The savings will, of course, vary between populations, because they depend on the tradition for admission of patients with suspicious symptoms, the prevalence of AMI in the population and the cost of hospitalization.
